Blue Cross and Blue Shield of Kansas · PayerPolicy · BCBSKS-GENETIC-BIOMARKER-TESTING-INCLUDING-LIQUID-BIOPSY-FOR-TARGETED-TREATMENT-IN-ADVANCED-CANCER
Source checked September 30, 2026 · Open the payer’s source
Summary of the payer’s published policy. Not a coverage determination — confirm with Blue Cross and Blue Shield of Kansas before submitting.
Blue Cross and Blue Shield of Kansas has replaced or withdrawn this version, and Backwork could not match it to a current one. The payer’s current policies are listed on its page.